Press releases

Food Emulsifiers Increase Pathogenicity of Certain Bacteria and Risk of Intestinal Inflammation

Diet is believed to play a role in triggering intestinal inflammation that can lead to the development of certain conditions, such as Crohn's disease. Researchers from Inserm, CNRS and Université de Paris have shown that the emulsifiers present in many processed foods ...
Press release | 26 Oct 2020 | Cell biology, development and evolution Genetics, genomics and bioinformatics Immunology, inflammation, infectiology and microbiology

A New Therapeutic Target for Type 2 Diabetes Discovered Thanks to a Rare Disease

A new therapeutic target for type 2 diabetes has recently been identified by researchers from Inserm and Université de Strasbourg, in collaboration with several European hospitals. ...
Press release | 16 Oct 2020 | Genetics, genomics and bioinformatics Circulation, metabolism, nutrition

The Placenta Could Retain a Memory of Tobacco Exposure Prior to Pregnancy

A study is showing for the first time that tobacco consumption, even when stopped before pregnancy, can have an impact on the placenta. Smoking not just during but also before pregnancy leads to epigenetic modifications (DNA methylation) which could have consequences on ...
Press release | 07 Oct 2020 | Cell biology, development and evolution Genetics, genomics and bioinformatics Public health

Covid-19 : 15 % des formes graves de la maladie s’expliquent par des anomalies génétiques et immunologiques

Pourquoi la réponse individuelle à l'infection par le virus SARS-CoV2 varie-t-elle autant d’une personne à l’autre ? Résoudre ce mystère permettrait d’identifier les patients à risque, d’anticiper et d’améliorer leur prise en charge et d’offrir de nouvelles voies thérapeutiques fondées sur une meilleure ...
Press release | 24 Sep 2020 | Covid-19 Genetics, genomics and bioinformatics Immunology, inflammation, infectiology and microbiology

A Novel Genome Editing Tool for Rare Hereditary Diseases

Researchers from Inserm, Université d’Evry, Université Paris-Saclay and Genethon have developed a novel platform for modifying the genome of hematopoietic stem cells, which give rise to blood cells. The use of these tools could provide new therapeutic solutions for many patients with ...
Press release | 14 Aug 2020 | Genetics, genomics and bioinformatics

Type 1 Interferon Deficiency: A Blood based Signature for Detecting Patients at Risk of Severe Covid-19

In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting of a severely impaired response of interferon (IFN) ...
Press release | 16 Jul 2020 | Genetics, genomics and bioinformatics
fermer
fermer
RSS Youtube